In contrast, adult AML LSCs tend to enter a more quiescent state, creating selective pressure that favors the acquisition of mutations in epigenetic regulators such as TET2 and DNMT3A [25]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.